ANGIOEDÈME BRADYCHINIQUE Bradykinin-mediated angioedema


angioneurotic edema
, bradykinin-mediated angioedema

How to Cite

GONZVA, J. ., Cervera , A., Lefort , H., Jost , D., & Tourtier , J. (2021). ANGIOEDÈME BRADYCHINIQUE Bradykinin-mediated angioedema. Mediterranean Journal of Emergency Medicine, (25), 40-41. Retrieved from


Angioneurotic edema is characterized by the occurrence of recurrent edema that can be localized at the extremities, abdominal or oropharynx level. Its management is considered a therapeutic emergency. We report the case of a 24-year-old patient suffering from an angioneurotic edema involving the tongue with irreducible protrusion. Its treatment is based on the emergency administration of icatibant or C1 esterase inhibitor concentrate available in reference healthcare centers.



Floccard B, Crozon J, Rimmelé T, Vulliez A, Coppere B, Chamouard V, et al. Management of bradykinin-mediated angioedema. Ann Fr Anesth Reanim 2011; 30:578-88.

Nosbaum A, Bouillet L, Floccard B, Javaud N, Launay D, Boccon-Gibod I, et al.; CREAK task force; French National Center for Angioedema. Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema. Rev Med Interne 2013; 34:209-13.